Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Reports Millions In Unpaid GDUFA Program Fees

07 Oct 2019

• By Derrick Gingery

Franklin Currency_1099429328_1200.jpg — The GDUFA carryover balance still increased in FY 2018 because collections again outpaced obligations. • Source: Shutterstock

Related Content

Generic User Fees Need Small Business Waiver, Firms Say; Congress May Agree

24 Jun 2013

User Fee Delinquencies Rising At US FDA After PDUFA Redesign

02 Oct 2019

Biosimilar User Fee Collections Drop Well Below Estimates, But US FDA Not Worried

10 Jun 2019

The Big Spend-Down: US FDA Eyes $159M Reduction In Carryover User Fees

08 Apr 2018

Inside The ANDA Parking Lot

14 Jun 2018

Is Bloom Gone From Rosy ANDA Approvals Figures?

12 Nov 2018

ANDA Submissions To US FDA Expected To Decline; Generic User Fees For FY 2019 Will Rise

29 Jul 2018

Generic Industry Consolidating But Still Mysterious

07 Jun 2017

Generic User Fee Hikes Could Disrupt US FDA Drug Pricing Campaign

28 Aug 2017

Generic Companies Race To Withdraw ANDAs

08 Jul 2019

FDA's GDUFA War Chest Grows, And Industry May Look For Lower Fees

08 Jun 2015

Additional Topics

United States Generic Drugs Review Pathway FDA Regulation BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.